all report title image
  • Published In : Dec 2023
  • Code : CMI4347
  • Pages : 190
  • Formats :
      Excel and PDF
  • Industry : Clinical Diagnostic
Ingographics Image

Polyclonal antibodies are immunoglobulin that bind nonspecifically to multiple epitopes of an antigen. They are commonly produced by injecting the antigen into an animal and harvesting the resulting serum containing the immunoglobulin. Factors such as the rising prevalence of various chronic and infectious diseases, increasing research and development investments in the pharmaceutical and biotechnology sectors, and the growing adoption of polyclonal antibodies for research applications are expected to drive the growth of this market. However, stringent regulatory guidelines for product approval may impede market growth to some extent. Polyclonal antibodies are a heterogeneous mix of antibodies derived from the immune response of multiple B-cells, in which each one recognizes a different epitope on the same antigen. Polyclonal antibodies are composed of a mixture of antibodies that represent the natural immune response to an antigen. Polyclonal antibodies are used in general research applications

Market Dynamics:

The global polyclonal antibody market is projected to grow at a steady pace during the forecast period owing to various driving factors such as rising prevalence of chronic and infectious diseases, and growing adoption in various research applications. Furthermore, ongoing innovations in diagnostic technology and a rapid shift towards polyclonal antibodies as an inexpensive alternative to monoclonal antibodies are expected to boost demand. However, the high costs associated with the purification and heterogeneity of polyclonal antibodies along with stringent regulatory approvals, pose major challenges to the market. On the other hand, development of advanced purification techniques, labeling processes, and recombinant antibody production creates growth opportunities during the forecast period

Key features of the study:

  • This report provides an in-depth analysis of the global polyclonal antibody market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global polyclonal antibody market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Santa Cruz Biotechnology, Inc., GenScript, Merck KGaA, Bio-Rad Laboratories, Inc., BioLegend, Inc., GeneTex, ROCKLAND IMMUNOCHEMICALS, INC., Abcam plc., Creative Diagnostics, Crown Bioscience, Takara Bio Inc., Geno Technology Inc., IGY Immune Technologies and Life Sciences Inc., EpigenTek Group Inc., Takeda Pharmaceutical Company Limited and SAB Biotherapeutics
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global polyclonal antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing global polyclonal antibody market

Detailed Segmentation:

  • Global Polyclonal Antibody Market, Type:
    • Primary Antibody
    • Secondary Antibody
  • Global Polyclonal Antibody Market, Source:
    • Rabbits
    • Goats
    • Sheep
    • Others
  • Global Polyclonal Antibody Market, By Application:
    • Academic Research
    • Diagnostics
    • Others
  • Global Polyclonal Antibody Market, By End User:
    • Academic & Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Others
  • Global Polyclonal Antibody Market , By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles
    • Thermo Fisher Scientific Inc.
    • Santa Cruz Biotechnology, Inc.
    • GenScript
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • BioLegend, Inc.
    • GeneTex
    • ROCKLAND IMMUNOCHEMICALS, INC.
    • Abcam plc.
    • Creative Diagnostics
    • Crown Bioscience
    • Takara Bio Inc.
    • Geno Technology Inc.
    • IGY Immune Technologies and Life Sciences Inc.
    • EpigenTek Group Inc.
    • Takeda Pharmaceutical Company Limited
    • SAB Biotherapeutics

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Source
      • Market Snapshot, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trend Analysis
    • Market Dynamics
      • Drivers
        • Increasing product launch
        • Partnerships among key market players
      • Restraints
        • The high costs associated with polyclonal antibody production
        • Stringent regulations
      • Market Opportunities
        • Growing applications of polyclonal antibodies in diagnostics
        • Adoption of recombinant polyclonal antibodies
    • Impact Analysis
    • Regulatory Guidelines
    • Product launches
    • Key Development
    • PEST Analysis
    • PORTER’s Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions
    • Manufacturer Revenue
    • Healthcare Spending by Country
  4. Global Polyclonal Antibody Market - COVID-19 Impact Analysis
    • Overall Impact
    • Government Initiatives
    • COVID-19 Impact on the market
  5. Global Polyclonal Antibody Market, By Type, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019-2030
      • Segment Trends
    • Primary Antibody
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
    • Secondary Antibody
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
  6. Global Polyclonal Antibody Market, By Source, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019-2030
      • Segment Trends
    • Rabbits
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
    • Goats
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
    • Sheep
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
    • Others (Rats, etc.)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
  7. Global Polyclonal Antibody Market, By Application, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019-2030
      • Segment Trends
    • Academic Research
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
    • Diagnostics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
  8. Global Polyclonal Antibody Market, By End User, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019-2030
      • Segment Trends
    • Academic & Research Institutes
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
    • Pharmaceutical and Biotechnology Companies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
    • Others (Diagnostic Centers, etc.)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Mn)
  9. Global Polyclonal Antibody Market , By Region, 2018-2030, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, For Country, 2019-2030
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2018- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018– 2030, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Source, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018– 2030, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Santa Cruz Biotechnology, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GenScript
      • Company Highlight
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck KGaA
      • Company Highlight
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BioLegend, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GeneTex
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ROCKLAND IMMUNOCHEMICALS, INC.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abcam plc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Creative Diagnostics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Crown Bioscience
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Takara Bio Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Geno Technology Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • IGY Immune Technologies and Life Sciences Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • EpigenTek Group Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SAB Biotherapeutics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  11. Section
    • Research Methodology
    • About Us

*Browse 44 market data tables and 37 figures on "Global Polyclonal Antibody Market” – Global forecast to 2030

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo